Mü ller glia can serve as a source of new neurons after retinal damage in both fish and birds. Investigations of regeneration in the mammalian retina in vitro have provided some evidence that Mü ller glia can proliferate after retinal damage and generate new rods; however, the evidence that this occurs in vivo is not conclusive. We have investigated whether Mü ller glia have the potential to generate neurons in the mouse retina in vivo by eliminating ganglion and amacrine cells with intraocular NMDA injections and stimulating Mü ller glial to re-enter the mitotic cycle by treatment with specific growth factors. The proliferating Mü ller glia dedifferentiate and a subset of these cells differentiated into amacrine cells, as defined by the expression of amacrine cell-specific markers Calretinin, NeuN, Prox1, and GAD67-GFP. These results show for the first time that the mammalian retina has the potential to regenerate inner retinal neurons in vivo.
I
t is well established that the retina of cold-blooded vertebrates regenerates very well after damage (1) (2) (3) . The avian retina is also capable of limited regeneration of new neurons following neurotoxic damage (4) . In both systems, damage to retinal neurons causes Müller glial cells to re-enter the cell cycle, after which they dedifferentiate into retinal progenitors, and ultimately differentiate into neurons. In fish, all types of neurons are regenerated. However, in chicks, only a limited number of different types of inner retinal neurons (amacrine, bipolar, and ganglion cells) are produced; few, if any, photoreceptors are regenerated.
In the mammalian retina, by contrast, the proliferative response of Müller glia to injury is even more limited than in chicks. In response to injury in mouse or rat retina, the Müller glia may become reactive and hypertrophy, but few re-enter the mitotic cell cycle. Due to the lack of a spontaneous regenerative response in the mammalian retina, several groups have attempted to stimulate regeneration with intraocular injections of growth factors and/or transcription factors, in vitro or in vivo (5) (6) (7) (8) (9) (10) . Taken together, the studies of the mammalian retina indicate that Müller glia have a very limited proliferative response to injury, but can be stimulated to re-enter the cell cycle after photoreceptor or inner retinal neuron injury. These studies also reported that some of the progeny of Müller glial mitotic divisions go on to differentiate characteristics of rod photoreceptors. However, these studies failed to detect regenerating inner retinal neurons after damage, unless they were transfected with genes that specifically promote amacrine fate (9) . This is puzzling, since in the chick, amacrine cells are the primary neuronal cells that are regenerated after injury. In an attempt to resolve this issue, we have carried out a systematic analysis of the response to injury in the mouse retina, and the effects of growth factor stimulation on Müller glial proliferation. The previous studies have used rats because of the relative ease of intraocular injections, but mice have the advantage that it is possible to use a variety of genetically manipulated animals to verify neural regeneration. We find that as in the rat, very few Müller glia re-enter the cell cycle after N-methyl-D-aspartic acid (NMDA) mediated damage to inner retinal neurons; however, the proliferation can be greatly stimulated by intraocular injection of either EGF, FGF1, or the combination of FGF1 and insulin. Although most progeny of the Müller glia maintain their expression of Müller glial markers, a small number of bromodeoxyuridine (BrdU) labeled cells differentiate into amacrine cells, as indicated by their expression of NeuN, Calretinin, Pax6, and GAD67-GFP. Thus, our results show for the first time that the mammalian retina has the potential to regenerate inner retinal neurons in vivo.
Results

Neurotoxic Damage and Stimulation of Proliferation. To test whether
Müller glia can regenerate inner retinal neurons in the mouse retina, we elicited retinal damage with NMDA. Overstimulation of NMDA-activated ionotropic glutamate receptors causes cell death of retinal ganglion cells (RGC) and amacrine cells (11) (12) (13) . We confirmed in adult mouse retina that NMDA induced damage leads to loss of Brn3-positive RGCs and GAD67-GFP GABAergic neurons, but not bipolar cells. (supporting information (SI) Fig. S1 A and B) .
Previous studies have found only limited Müller glia proliferation after various forms of retinal injury in the mammalian retina; however, a recent report shows that retinal damage causes increased EGF receptor expression in Müller glia (5) . We therefore reasoned that NMDA induced damage to the retina might elicit a similar increase in the sensitivity of Müller glia to EGF. Previous studies in chick retina demonstrated that the combination of FGF and insulin also stimulated proliferation of Müller glia. Therefore, we made intraocular injections of either EGF or the combination of FGF and insulin in adult mice that had received an injection of NMDA two days previously (Fig.  1A) . At this time, the mice also received BrdU to identify any cells that re-entered the cell cycle. We found that there were few BrdUϩ cells 24 h following an injection of EGF in undamaged retina ( Fig. 1B ; 24 h after EGF), but there was a large, dose dependent increase in proliferation in animals that received EGF after prior NMDA-induced damage ( Fig. 1 C and D) .
We analyzed the distribution of the proliferating cells (BrdUϩ) in NMDA/EGF-treated retinas in flatmount preparations at various time points after treatment. Systematic quantitative analysis of cell proliferation in mouse retina over time was conducted by counting BrdUϩ nuclei on confocal images taken across the entire depth of flatmounted retina (Fig. S1C) . Injection of either NMDA or EGF alone did not induce substantial proliferation in the retina (Fig. 1 B, E, and G) . By contrast, NMDA at day zero (d0) followed by a single injection of EGF 48 h later (d2) resulted in a striking increase in proliferation across the retina (day 3: Fig. 1 F-H) . Even as early as 4 h after the EGF injection there were up to 1728 BrdUϩ cells/mm 2 (1168 Ϯ 203 BrdUϩ cells/mm 2 , n ϭ 4, Fig. 1H ). The number of BrdUϩ cells declined over the next week (Fig. 1H, S2 B-D Several previous reports have found that in fish, birds, and mammals, Müller glia make up the majority of cells that re-enter the mitotic cycle after retinal damage, although vascular cells, astrocytes and microglia also proliferate after damage (14) (15) (16) . To confirm that Müller glia were among the cells that take up BrdUϩ after NMDA treatment in our experiments, we carried out double-label immunofluorescence for BrdU and Sox2 or Sox9, both nuclear markers for Müller glia (17) (18) (19) . The Müller cell specific expression was confirmed by co-labeling sections with one of two well-characterized Müller glia markers: cellular retinaldehyde binding protein (CRALBP; Fig. 2 A and B) or a glial high affinity glutamate transporter, called solute carrier family 1 member 3 (GLAST; data not shown). Moreover, GFAP (glial fibrillary acidic protein) is up-regulated in many Müller glia after damage and therefore these cells can be labeled in mice with Cre-recombinase driven by GFAP crossed to ROSA-EYFP reporter mice (ϭ GFAP-Cre::EYFP) ( Fig. 2 C and D) . Damaging adult mouse retina with NMDA and subsequently stimulating proliferation with various growth factors showed that as early as 4 h after the mitogen, many of the BrdUϩ cells were also Sox2ϩ or Sox9ϩ, residing in the presumptive Müller glia sublayer of the INL (Fig. 2 E and G) . Many of the GFAP-Cre::EYFP positive Müller cells are PCNA positive after damage and growth factor injections (Fig. 2F) . We also observed GFAP-Cre::EYFP cells co-labeled for other mitotic markers: BrdU, Ki67, and PH3 ( Fig. 2 H 
-J).
To determine if mouse Müller glia dedifferentiate and to assess whether genes relevant to neurogenesis were re-expressed in these cells when they are stimulated to proliferate with injections of EGF after NMDA damage, we carried out several types of studies. Using immunohistochemistry we found that Müller glia acquire characteristics of retinal progenitors after NMDA/growth factor treatment, shown by their expression of the transcription factor Pax6. Pax6 is normally expressed by retinal progenitors in developing retina and in inner retinal neurons (amacrine/RGCs). Pax6 re-expression is a welldocumented step in the dedifferentiation of Müller glia after damage of the fish and chick retina in vivo (20) (21) (22) as well as adult rat retina in vitro (10) . Following NMDA induced retinal damage and intraocular injections of either EGF or the combination of FGF1 and insulin, the majority of GFAP-Cre::EYFP positive Müller glia are also Pax6 positive (Fig. 2K) .
We have recently reported in the chick retina that many genes normally expressed only in developing retina are re-expressed following NMDA induced damage (23) . To assess whether the same genes are up-regulated in mouse retina, we used a similar approach. We harvested mouse retinas 4 h after EGF injection (d2), 24 h (d3), 48 h (d4) and seven days later (d9) (Fig. S3A) . The left eyes were injected, while the right eyes served as uninjected controls; we used semiquantitative real-time PCR to measure changes in gene expression. Over the time course studied, Notch1 and one of its ligands, Delta1, were both significantly increased, as well as other progenitor specific genes, FoxN4 and Pea3. Two additional progenitor-specific genes, Ascl1 and Neurogenin2 were not up-regulated to levels detectable by RT-PCR (Fig. S3 B and C) ; however, the RT-PCR changes we observe are likely to miss small changes in expression or even large changes if they are in a small number of cells. Nevertheless, these experiments show that at least a part of the developmental program relevant to neurogenesis is re-expressed in the mouse (Fig. 3A) , suggesting that some of the BrdUϩ cells differentiate into amacrine cells. To investigate whether BrdUϩ cells were differentiating into amacrine or ganglion cells, we immunolabeled flatmounts or sections from NMDA-damaged and growth factor-treated retinas with antibodies against BrdU and one of two markers of amacrine and ganglion cells: NeuN or Calretinin. Fig. 3 shows examples of cells expressing both BrdU and each of these markers. The double-labeled cells were found in either the ganglion cell layer (GCL) or the inner nuclear layer (INL) and had morphologies similar to the other neurons in these layers. We found BrdUϩ/NeuNϩ cells five days following the growth factor injection in both the EGF and FGF1/ insulin treatment groups (Fig. 3B) . In either of those two treatments between one and three double-labeled NeuNϩ/BrdUϩ cells were present in z-stacks across a 0.05 mm 2 retinal area (Table 1) . Using a second marker for amacrine cells and RGC, Calretinin, we also found double-labeled cells five days after EGF or FGF1/insulin treatment. These experiments show that some of the cells that incorporated BrdU after retinal damage and subsequent growth factor treatment developed characteristics of inner retinal neurons.
To further confirm that new neurons are produced in the NMDA-treated retina, we used a GAD67-GFP transgenic reporter mouse, which labels GABAergic cells in the retina. As in previous experiments, we induced inner retinal neuronal damage with NMDA; however, instead of giving single injections of growth factors as above, we made multiple injections of FGF1/ insulin to increase their potential for neural differentiation. For these experiments, we co-injected FGF1 and insulin once daily, for four consecutive days (4xFGF1ϩinsulin) after NMDA damage, and analyzed the retinas at day (Fig. 3 D-J) . We also observed cells triple labeled for BrdUϩ/GFPϩ/Prox1ϩ (Fig. 3H) . Overall, 3.6% of the BrdUϩ cells (0.04% of all Müller glia) differentiate into GAD67-GFP cells. The location and morphology of the BrdUϩ/GFPϩ cells suggested that these new neurons in the INL are amacrine cells; however, both markers are also expressed in horizontal cells, and so we cannot rule out that some of the BrdUϩ cells are new horizontal cells. We failed to find BrdUϩ/ Brn3ϩ cells, and so it is unlikely that any new ganglion cells are generated in our paradigm. We also analyzed the retinas for the presence of new ganglion cells and bipolar cells. For the bipolar cell analysis, we used a reporter mouse line that expresses EGFP under the metabotropic glutamate receptor 6 (Grm6-GFP) (24) . For analysis of ganglion cells, we used an anti-Brn3 antibody. After NMDA damage, we did not find any evidence for BrdUϩ/ Grm6-GFP bipolar cells (Fig. S4) or BrdUϩ/Brn3ϩ ganglion cells in retinas treated with EGF or FGF1 and insulin. Since Ooto, et al. (9) reported that retinoic acid (RA) promotes bipolar generation of damaged adult rat retina in vivo, we also tested whether RA treatment after NMDA damage would promote new bipolar cell differentiation; however, we found no BrdUϩ/Grm6-GFP cells.
Discussion
We have found that Müller glia can be induced to proliferate in vivo after NMDA induced neuronal degeneration, by subsequent injections of EGF, FGF1, or a combination of FGF1 and insulin. The proliferation of the Müller glia occurs across the retina, regardless of eccentricity. Stimulation of proliferation after NMDA damage also caused an up-regulation of progenitor markers (Pax6, Notch, Dll1) similar to what has been reported for retinal regeneration in non-mammalian vertebrates-fish and chick (3, 23, 25, 26) . Stimulation of proliferation in the NMDA-treated retina led to differentiation of some of the Müller glial progeny into cells that express many features of retinal amacrine neurons, including Calretinin, NeuN, Pax6, Prox1, and GAD67-GFP. These results show for the first time that the mammalian retina has the potential to regenerate inner retinal neurons in vivo.
Although we find that Müller glia make up the majority of the cells that incorporate BrdU in our damage/growth factor protocol, three other cell populations are known to proliferate after damage in the retina: astrocytes, microglia, and endothelial cells (14) (15) (16) . In our study, most of the proliferation of the astrocytes and endothelial cells takes place in the ganglion cell layer and is clearly separated from that of the Müller glia. Given previous results in fish and chicks (see below) that Müller glia are the source of new neurons after retinal damage and the data showing that many of the BrdUϩ cells express Müller glial markers after damage in the mouse (this study), it is likely that the BrdUϩ inner retinal neurons we find are the progeny of Müller glia; however, we cannot rule out the possibility that endothelial cells, microglial cells, or astrocytes are the source of the new neurons.
It has long been recognized that poikilothermic vertebrates are capable of a remarkable degree of retinal regeneration (1-3). Teleost fish regenerate new retinal neurons following neurotoxin damage or surgical lesions through a blastema-like population of progenitor cells that arises adjacent to the site of injury. The fish retina contains at least two potential sources of progenitor cells: the mitotically active rod progenitors and Müller glia. For many years, it was thought that the rod progenitor was the primary source of regenerated neurons following damage; however, recent studies using transgenic GFP reporter fish, have shown that the primary source of regenerated neurons in the fish retina are the Müller glia (21, (27) (28) (29) . These cells are normally mitotically quiescent, but following damage to retinal neurons, they re-enter the cell cycle, dedifferentiate, and express progenitor genes, like Ascl-1 and Notch pathway components. The chick retina has a more limited regenerative capacity, although there are many similarities with the fish (4, 23) . Neurotoxic damage of inner retinal neurons with NMDA in posthatch chicks leads to a robust proliferative response and as in the fish, the proliferating Müller glia dedifferentiate and express retinal progenitor genes (20) . Some of the progeny spontaneously differentiate into amacrine cells and bipolar cells.
While most mammalian Müller glia do not spontaneously re-enter the mitotic cycle after neurotoxic damage, as they do in the bird and fish, Ooto, et al. (9) found a small number of Müller glia incorporated BrdU in the rat retina after NMDA treatment. Other studies, have also reported that application of EGF, Shh, Wnt, or insulin and FGF stimulates Müller glia proliferation in adult rats following retinal damage in vivo or in vitro (5) (6) (7) (8) (9) (10) 30) . These previous studies have also reported that some of the progeny of the Müller glia can also express markers of retinal photoreceptors. BrdUϩ photoreceptors have been reported after NMDA damage (9), photoreceptor degeneration due to culture (10) , in vivo following N-methyl-N-nitrosourea (MNU) (7, 8) or direct Müller glial stimulation with alpha-aminoadipate (6). Thus, outer retinal regeneration appears to be favored in the rat, while in the chick, definitive evidence for photoreceptor regeneration has not been obtained. In this study, we have found that the mammalian retina can regenerate inner retinal neurons, most likely amacrine cells, similar to the avian retina (20) . Interestingly, one of the most highly up-regulated genes in both the mouse retina (Fig. S3 ) and the chick retina following NMDA-induced damage is FoxN4 (23), a transcription factor that biases retinal progenitor cells toward an amacrine cell fate.
Despite the similarities in amacrine cell regeneration, there is a striking difference between the fish and chick retinal response to injury and that of the mouse or rat: Müller glia robustly and spontaneously re-enter the mitotic cell cycle following injury in the former but not in the latter. The absence of a spontaneous proliferative response in mammalian Müller glia suggests that some mechanisms are in place to limit proliferation in these cells in the adult. Close, et al. (31) investigated this question and determined that there are at least two molecular mechanisms in place that maintain mammalian Müller glia in a mitotically quiescent state. Tgf␤2, produced by retinal neurons, activates the TgfßR in progenitors, stimulating expression of the cyclin dependent kinase inhibitor, p27 kip . In addition, the EGF receptor expression in Müller glia gradually declines as the retina matures, and the loss of a receptor for this important retinal mitogen also promotes cytostasis. Close, et al. (5) reported that light induced photoreceptor degeneration in albino rats caused an up-regulation in the EGF receptor in Müller glia, which allowed them to be driven into the S-phase by intraocular EGF injections. In the present study, we have confirmed and extended these results, showing that either retinal damage or EGF injections alone fail to elicit a proliferative response, but both treatments together produce a robust response in mouse retina. In addition, we have found that EGF and FGF can stimulate Müller glial proliferation after damage in vivo. Similar results have been obtained in rat retina, either cultured as explants, or after MNU treatment, which both lead to the damage of retinal photoreceptors. In these reports, the combination of retinal damage, coupled with mitogen treatment, was required to stimulate Müller proliferation (7, 8, 10) .
Taken together with earlier reports, it appears that at least some of the regenerative phenomena displayed in the fish and chick retina can be stimulated in the mouse retina. While many of the progeny of the Müller cell divisions die within the first week after their production, the subset that survive are stable to at least 30 days and differentiate characteristics of amacrine cells (and possibly horizontal cells). Many reports of adult neurogenesis/neuronal replacement have noted that between 50 and 80% of the newly generated neurons are eliminated (32-36) within a few weeks after they have been generated. It is not clear why this occurs, although it has been speculated that the new cells must make stable synaptic connections to survive. In zebrafish, where functional retinal regeneration of all types of neurons occurs after damage, only approximately 30% of the original BrdUϩ Müller glia or their progeny remain after two weeks (27) .
Therefore, it is possible that endogenous repair mechanisms can be stimulated in this system for replacement of other types of retinal neurons. The process of dedifferentiation in the fish, avian, and mouse retina are remarkably similar; the Müller glial cells respond to damage (and mitogens) by re-entering the cell cycle, expressing key components of the neurogenic program of retinal progenitors and producing new neurons. In the case of the fish, the new neurons are functionally integrated into the existing circuitry, although this remains to be demonstrated in chicken or mammals. Müller glia exist in all vertebrate retinas, so the cellular source for regeneration is present in the human retina. Further understanding of the limits in its potential may lead to new treatments for retinal degenerations.
Materials and Methods
Mice were housed in the Department of Comparative Medicine at the University of Washington and maintained under a 12 h light/dark cycle with access to food and water ad libitum. The GAD67-GFP (37) and Grm6-GFP (24, 38) transgenic mice used in this study were described previously. GFAP-Cre (39) mice were crossed onto B6.129 ϫ 1-Gt(ROSA)26Sortm1(EYFP)Cos/J (Jackson Laboratory, #006148) reporter mice (ϭ GFAP-Cre::EYFP). The use of animals in this study was in accordance with approved protocols and the guidelines established by the University of Washington, IACUC, and the National Institute of Health.
For in vivo studies, mice were anesthetized and graded glass micropipettes with a fine tip aperture were used to inject the left eyes with 2 l of 0.1 M NMDA, various growths factors, or control solutions. Any intraocular injection after the NMDA injection to the same animal included 1 mg/ml BrdU with a final volume of 2 l/eye. Factors were injected at the following final concentrations unless indicated otherwise: 1 g/l EGF (R&D, recombinant mouse), 100 ng/l FGF1 (R&D, bovine), 1 g/ul insulin (Sigma, bovine), and 0.3 M/ul all-trans retinoic acid (Sigma). In addition, animals received BrdU (50 g/g BW) by i.p. injection. Mice were killed at various time points after the injections and retinas were either processed for RNA extraction or immunohistochemistry and subsequent confocal microscopic analysis (Fig. S1 and Table S1 ).
For additional information, see SI Text.
